NFKB1 and glaucoma: Fingolimod/FTY720 is found to inhibit NFκB and pro-inflammatory cytokines in the retina of diabetic rats, preventing disruption of the blood-retinal barrier; in addition, FTY720 reduces neuronal loss in rats with glaucoma (49, 50).